ArticleMethods in molecular biology (Clifton, N.J.)2025
Structure-Based Epitope Profiling with the Structural Profiling of Antibodies to Cluster by Epitope 2 (SPACE2) Algorithm.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computational epitope profiling methods group antibodies that bind to the same epitope. They can be used to predict epitopes and reduce the number of antibodies that need to be characterized experimentally. Conventionally, computational epitope profiling is achieved by clustering antibodies by sequence similarity. While sequence-similar antibodies are likely to share a common function, such methods neglect that antibodies with highly diverse sequences can exhibit similar binding site geometries and engage common epitopes. The SPACE2 algorithm described here is an epitope profiling method that clusters antibodies based on the structural similarity of models predicted with a state-of-the-art protein structure prediction tool. SPACE2 accurately clusters antibodies that engage the same epitope and exhibits far greater data coverage than conventional methods. Furthermore, SPACE2 detects signals of functional convergence and, unlike sequence-based methods, is able to link antibodies diverse in sequence, genetic lineage, and species origin. These results reiterate that structural data provides orthogonal information to sequence and improves our ability to study antibodies and their epitopes.
Indexed as
Identifiers
40593426What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.